Related Experiment Video
Updated: Sep 23, 2026

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
Published on: September 12, 2016
Demyelinating neuropathies
1Department of Neurology, Johns Hopkins University, Baltimore, Maryland 21287, USA.
Purpose Of Review:
To review recent advances in heritable demyelinating neuropathies and their genotype-phenotype correlations.
Recent Findings:
Two themes dominated the literature on demyelinating neuropathies in the past 2 years: (1) the dissection of the localization and roles of new molecules in the axon-Schwann cell unit, including periaxin and connexin32, which are mutated in specific heritable neuropathies; (2) the recognition of the range of phenotypes associated with individual genetic abnormalities, so that the same defects can even produce both demyelinating and axonal forms of heritable neuropathies. The axonal injury associated with demyelination reflects elaborate interactions between axons and Schwann cells.
Summary:
Demyelinating neuropathies, even those due to abnormalities in intrinsic Schwann cell or myelin proteins, can have clinical manifestations due to distally predominant axonal degeneration.
More Related Videos
Related Concept Videos
Multiple Sclerosis l: Introduction
Diabetic Neuropathy
Disorders of the Nervous Tissue
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
Encephalitis ll: Pathophysiology
Diphtheria
Secondary Spinal Cord Injury llI: Pathophysiology

